Abstract. Maternally expressed gene 3 (MEG3) �n r�e�-�n r�e�-mato�d art�r�t�s (RA) and �ts �nderly�ng mec�an�sm were explored. Synov�al t�ss�es from 10 RA pat�ents and 10 controls were collected to detect MEG3 express�on �n fibroblast-like synoviocytes (FLS). The relationship between MEG3 expression and TNF-α was analyzed. After MEG3 knockdown by lentivirus transfection, cell cycle, proliferation, apoptosis, invasion and secretion of inflammatory factors were detected. Furthermore, the effect of MEG3 on STAT3 and PI3K/AKT pat�ways was explored. MEG3 was downregulated in RA patients, and exogenous TNF-α treatment co�ld decrease MEG3 express�on. After transfection with lentivirus, downregulated MEG3 led to FLS proliferation and secretion of inflammatory cytokines, IL-6 and IL-8, improved the invasive ability and inhibited apoptos�s. Reverse transcr�pt�on-q�ant�tat�ve polymerase c�a�n react�on (RT-qPCR) res�lts revealed t�at downreg�lated MEG3 �ncreased t�e express�on levels of MMP2 and MMP9. Western blotting results showed that downregulated MEG3 act�vated STAT3 and PI3K/AKT pat�ways. Downreg�lated MEG3 was able to promote proliferation and invasion, and inhibit apoptosis of FLS via STAT3 pathway.
Introduction
R�e�mato�d art�r�t�s (RA) �s a common c�ron�c and a�to-�mm�ne d�sease, w��c� �s ma�nly man�fested as t�e jo�nt �nvolvement, �lt�mately res�lt�ng �n jo�nt destr�ct�on, deform�ty and limb movement disorders. RA leads to a heavy economic and psychological burden on patients and society. Therefore, �t �s of great s�gn�f�cance to �mprove t�e early d�agnos�s, t�mely treatment and effect�ve control of RA progress�on (1) . Recent studies have confirmed that the abnormal proliferation of T-lymphocytes and fibroblast-like synoviocytes (FLS) is the main cause of RA (2, 3) . Therefore, inhibition of FLS may assist with improvement of the treatment efficacy of RA. In addition to the stimulation of inflammatory factors, FLS apoptosis is also an essential cause of abnormal proliferation of RA (4) .
Long non-coding RNA (lncRNA) is a kind of RNA molec�le w�t� >200 n�cleot�des �n lengt�, w��c� does not �ave t�e f�nct�on of translat�ng prote�ns (5) . In�t�ally, researc�es on non-cod�ng RNAs were ma�nly foc�sed on m�croRNAs, and lncRNAs were considered to be only waste products of t�e genome. However, acc�m�lat�ng st�d�es �ave s�own t�at lncRNAs are greatly involved in biological processes. Studies have found that lncRNA expression is tissue-and cell-specific, which is capable of regulating gene expression levels and cell�lar processes at ep�genet�c, transcr�pt�onal and post-transcr�pt�onal levels (6, 7) .
Maternally expressed gene 3 (MEG3) �s a ��man �omo-log�e of t�e mo�se maternal gene Gtl2, w��c� �s ��g�ly conserved �n evol�t�on. MEG3 �s located on ��man c�ro-mosome 14q32.3 with ~1.6 kb in length. Genome structural analys�s �as revealed t�at MEG3/Glt2 cons�sts of 10 exons. Studies have confirmed that MEG3 is not a typical antisense sequence of gene transcript, but belongs to a kind of regulatory lncRNA w�t� t�mor s�ppressor f�nct�on (8) . MEG3 �s fo�nd to be overexpressed in normal tissues such as the pituitary gland, brain tissue, and placenta. Downregulated or absent MEG3 is observed in tumors, such as liver and lung cancer. MEG3 is also associated with tumor grade and prognosis. Functionally, MEG3 part�c�pates �n cell cycle, prol�ferat�on, metastas�s and apoptos�s of t�mor cells (9, 10) . T�e role of MEG3 �n RA, however, needs to be further elucidated.
Patients and methods
Cell isolation and culture of FLS. Ten RA pat�ents w�o received knee arthroscopic surgery and 10 trauma patients who received knee arthroscopic surgery in Peking Union Med�cal College Hosp�tal (Be�j�ng, C��na) were selected. T�e 10 RA pat�ents were 3 males and 7 females, 51.1±12.0 years of age. T�e 10 tra�ma pat�ents were 8 males and 2 females, 41.4±12.7 years of age. This study was approved by the Ethics
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Committee of Peking Union Medical College Hospital. Signed informed consents were obtained from the patients or t�e g�ard�ans.
Synovial tissues were collected during knee arthroscopic s�rgery. After gr�nd�ng, d�gest�on and centr�f�gat�on at 2,500 x g at 20˚C for 10 min, FLS were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) (both from Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 100 U/ml penicillin and 100 µg/ml streptomyc�n (HyClone; GE Healt�care, C��cago, IL, USA), and were incubated in a 5% CO 2 incubator at 37˚C. Cells �n logar�t�m�c growt� p�ase were �sed for t�e follow�ng exper�ments after cell passage 4-8 t�mes.
Cell transfection. Cells were transfected w�t� LV-Vector or LV-shMEG3, after cell confluence was up to 60%. Polybrene was added at a final dose of 4 µg/ml. Fresh medium was replaced every 4-6 �. All lent�v�r�ses were p�rc�ased from GeneP�arm (S�ang�a�, C��na).
TNF-α treatment. TNF-α (10 µg) was d�ssolved �n ster�le water to a final dose of 500 ng/µl, which was then collected into 200 µl EP tubes and preserved at -20˚C. Cells were treated with 10 ng/ml recombinant TNF-α for 24 h, followed by determination of inflammatory factors and related genes in FLS.
Cell proliferation assay. Cell s�spens�on was prepared and seeded �nto 96-well plates w�t� 4x10 3 /well. Cell Co�nt�ng K�t-8 (CCK-8) sol�t�on (10 µl) (Doj�ndo, K�mamoto, Japan) was added �n eac� well after cells were c�lt�red for 24, 48 and 96 h, respectively. The absorbance of each sample at 450 nm was measured by a microplate reader (Bio-Rad Laboratories, Inc., Herc�les, CA, USA).
Cell apoptosis assay. For cell apoptosis detection, 200 µl of binding buffer were added to prepare single cell suspension. In total 5 µl of Annex�n V-APC and 10 µl of 7-AAD (T�ermo Fisher Scientific, Inc.) were mixed in cell suspension and incubated in the dark for 15 min, followed by cell apoptosis detection using flow cytometry (BD Biosciences, Franklin Lakes, NJ, USA). The data were analyzed using FlowJo software (FlowJo LLC, Ashland, OR, USA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was extracted from cells by TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and then transcribed into complementary deoxyribonucleic acid (cDNA) using the PrimeScript RT reagent kit (Takara B�otec�nology Co., Ltd., Dal�an, C��na). qPCR was subsequently performed in strict accordance with the manufacturer's �nstr�ct�ons of SYBR Green Real-T�me PCR Master Mix (Invitrogen; Thermo Fisher Scientific, Inc.), with a total react�on vol�me of 10 µl. T�e follow�ng t�ermocycl�ng cond�-tions were used: denaturation at 95˚C for 1 min, annealing at 95˚C for 30 sec and extension at 60˚C for 40 sec, for a total of 40 cycles. GAPDH served as t�e �nternal control. T�e relat�ve express�on levels of genes were expressed as 2 -ΔΔCq (11) . T�e pr�mer seq�ences �sed �n t��s st�dy were as follows: MMP1 forward, AAAATTACACGCCAGATTGCC and reverse, GGTGTGACATTACTCCAGAGTTG; MMP2 forward, GAG GAGCAGTTACGGTCTGTG and reverse, TCCTTTCCTTA GCTGACACTTGT; MMP3 forward, AGTCTTCCAATCCT ACTGTTGCT and reverse, TCCCCGTCACCTCCAATCC; MMP9 forward, TGTACCGCTATGGTTACACTCG and reverse, TGGCTTCCATAGAGTTCCTTCC; MEG3 forward, CAGCCAGAGTTAGCACAATAGG and reverse, CTGTTG TTCCCGTCGGAGTT; GAPDH forward, AGGTCGGTG TGAACGGATTTG and reverse, TGTAGACCATGTAGT TGAGGTCA.
Western blotting. Total prote�n was extracted from t�e treated cells by radioimmunoprecipitation assay (RIPA) solut�on (Roc�e D�agnost�cs, Basel, Sw�tzerland). Total prote�n concentration was calculated by bicinchoninic acid (BCA) Protein Assay kit (Pierce; Thermo Fisher Scientific, Inc., Rockford, IL, USA). The protein sample was separated by electrophoresis on 10% sodium dodecyl sulphate-polyacrylam�de gel electrop�ores�s (SDS-PAGE) and t�en transferred to a polyvinylidene fluoride (PVDF) membrane (EMD Millipore, B�ller�ca, MA, USA). A total of 30 µg of prote�n were added per lane for t�e electrop�ores�s. After the membranes were blocked with 5% BSA at 20˚C for 1 h, they were incubated with primary antibodies overnight at 4˚C. The membranes were then washed with Tris-buffered saline with Tween-20 (TBST) and followed by incubation of secondary antibody. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL) detection kit (Amersham; GE Healthcare, Foster City, CA, USA). The gray value was analyzed using ImageJ software (vers�on 1.38; Nat�onal Inst�t�tes of Healt�, Bet�esda, MD, USA). Pr�mary mo�se monoclonal STAT3 antibody (dilution, 1/500; cat. no. ab119352); rabbit polyclonal PI3K antibody (dilution, 1/500; cat. no. ab70912); rabbit polyclonal AKT antibody (dilution, 1:500; cat. no. ab8805); rabbit monoclonal Bax antibody (dilution, 1/500; cat. no. ab32503); rabbit polyclonal Bcl-2 antibody (dilution, 1/500; cat. no. ab59348); rabbit polyclonal GAPDH antibody (dilution, 1:500; cat. no. ab37168) and secondary goat anti-rabbit (HRP) IgG antibody (dilution, 1:2,000; cat. no. ab6721) were all purchased from Abcam (Cambridge, MA, USA).
Enzyme-linked immunosorbent assay (ELISA)
. FLS in good cell growt� were collected and seeded �nto 6-well plates at a dose of 5x10 3 /well, w�t� 2 repl�cates �n eac� gro�p. Cells were treated with TNF-α for 24 h, followed by supernatant collection. Vascular endothelial growth factor (VEGF) express�on �n cell s�pernatant was detected accord�ng to the manufacturer's instructions of ELISA kit (BioLegend, Inc., San D�ego, CA, USA). Eac� exper�ment was repeated 3 t�mes.
Transwell assay. The upper Transwell chamber was previously coated w�t� Matr�gel (BD B�osc�ences, San Jose, CA, USA) and maintained in an incubator for 2 h. A total of 20 µl of cell supernatant and 500 µl of DMEM containing 5% FBS were then added in the upper and lower chamber, respectively. Transwell chamber was removed after 24 h-incubation, and the non-migrated cells in the chamber were gently wiped off with a cotton swab. The chamber was fixed with methanol for 15 min, washed with PBS twice and stained in 1% crystal violet for 30 min. Finally, 5 randomly selected fields were captured under an inverted microscope (magnification, x40; type, AZ100; Nikon Corp., Tokyo, Japan) for cell count.
Statistical analysis. All stat�st�cal analyses were cond�cted �s�ng Stat�st�cal Prod�ct and Serv�ce Sol�t�ons (SPSS) 16.0 software (SPSS, Inc., C��cago, IL, USA). Meas�rement data were expressed as mean ± standard dev�at�on. Inde pendent-sample t-test was used to compare the differences between two groups. P<0.05 was considered to indicate a statistically significant d�fference.
Results

MEG3 is downregulated in FLS of RA patients.
We f�rst extracted mRNAs of FLS from RA patients and controls. T�e res�lts �nd�cated t�at t�e mRNA level of MEG3 was downregulated in FLS of RA patients compared with that of controls (Fig. 1A) . In vitro experiments also showed that TNF-α treatment could remarkably inhibit MEG3 expre ssion in FLS �n a t�me-dependent manner, w��c� ac��eved t�e lowest level at 24 h (Fig. 1B) . We therefore utilized lentivirus tra nsfection to decrease MEG3 expression in FLS, so as to further explore the underlying potential of MEG3 (Fig. 1C) .
Downregulated MEG3 promotes proliferation and invasion of FLS.
The proliferative ability of FLS was remarkably increased after MEG3 knockdown, which achieved the peak at 72 h ( Fig. 2A) . Cell apoptosis results demonstrated a decreased apoptotic rate in FLS after MEG3 was inhibited (Fig. 2B) . No significant difference was observed in cell cycle after MEG3 knockdown (Fig. 2C) . Furthermore, the Transwell assay elucidated that downregulated MEG3 could remarkably promote the invasive ability of FLS compared to that of negative (Fig. 2D) . Prev�o�s st�d�es �ave po�nted o�t t�at matr�x metalloprote�n-ases (MMPs) are �nvolved �n t�e development and progress�on of RA. Hence, we spec�lated t�at MEG3 co�ld affect MMPs express�on levels. O�r data demonstrated t�at downreg�lated MEG3 co�ld lead to �ncreased express�on levels of MMP2 and MMP9, but there were no significant differences in MMP1 and MMP3 (Fig. 2E) . Cytokine secretion was also detected and the results revealed that downregulated MEG3 could remarkably promote the secretion of IL-6 (Fig. 2F) and IL-8 (Fig. 2G) after TNF-α treatment. Downregulated MEG3 stimulates STAT3 pathway. It has been reported t�at STAT3 �s greatly �nvolved �n cell apoptos�s of RA (12) . As a conseq�ence, we spec�lated t�at MEG3 co�ld reg�late RA v�a STAT3 pat�way. In t�e present st�dy, o�r data �nd�cated t�at downreg�lated MEG3 co�ld not only promote the phosphorylation of STAT3 (Fig. 3A) , but also regulate t�e express�on levels of t�e downstream factors of STAT3 (Fig. 3B) . Considering the crucial role of PI3K/AKT in cell proliferation, we detected the key factors �n t��s pat�way and found that downregulated MEG3 was also capable of stimulating the PI3K/AKT pathway (Fig. 3C) .
Discussion
RA �s a system�c a�to�mm�ne d�sease, w��c� �s c�aracter�zed by synovial hyperplasia, articular cartilage destruction and subchondral bone erosion (13) . Interact�on of var�o�s �mm�ne cells and inflammatory factors leads to FLS act�vat�on w�en t�ey are �nder var�o�s st�m�l�, s�c� as t�e env�ronment c�ange, smoking and sex hormones alteration. Activated FLS in turn secrete a variety of chemokines and inflammatory factors, which further stimulate FLS proliferation from the original 4 layers to 10 layers. T�e cont�n�o�sly prol�ferat�ng and act�-vating FLS gradually transform into RA-FLS, which present t�e c�aracter�st�cs of t�mor cells s�c� as red�ced apoptos�s, enhanced invasiveness, and secretion of cytokines, MMPs and proteoglyases, thereby destroying structures of articular cartilage and bone (14) . In this experiment, we found that MEG3 was downregulated in FLS of RA patients. In vitro exper�ments showed that TNF-α negat�vely reg�lates MEG3 express�on. Also, downregulated MEG3 was found to lead to FLS proliferat�on, secret�on of IL-6 and IL-8, �ncreased express�on levels of MMP2 and MM9, and to inhibite FLS apoptosis.
O�r res�lts also s�owed t�at downreg�lated MEG3 activates STAT3 pathway. It has been reported that STAT3 possesses two p�osp�orylat�on s�tes t�at are related to cell�lar f�nct�on, namely STAT3 (Y705) and STAT3 (S727) (15) . STAT3 �s presented �n t�e cytoplasm �n an �nact�ve form. Once t�e tyros�ne res�d�e of STAT3 (Tyr705) �s p�osp�ory-lated, STAT3 �nd�ces t�e p�osp�orylat�on of tyros�ne-SH2 reg�on to form a STAT3 d�mer. T�e STAT3 d�mer f�rt�er translocates into the nucleus and binds to STAT-specific DNA react�on fragments, t��s act�vat�ng a ser�es of downstream gene express�on levels (16, 17) . O�r exper�ment conf�rmed that MEG3 results in increased expression levels of RA-FLS, pSTAT3-705 and pSTAT3-727 in vitro. Moreover, downreg�-lated MEG3 activates STAT3 pathway in RA-FLS.
Bcl-2 is a member of the Bcl-2 family with anti-apoptotic capac�ty, w��c� �s an essent�al downstream of STAT3 pat�way (18, 19) . Here�n, we fo�nd t�at Bcl-2 �s related to RA-FLS apoptosis. In vivo st�d�es s�owed a ��g�er Bcl-2 express�on �n t�e synov��m of RA pat�ents t�an t�at of osteoart�r�t�s pat�ents. Prev�o�s st�d�es �ave conf�rmed t�at t�e stability of mitochondrial RA-FLS is regulated by Bcl-2, which exerts a crucial role in cell viability. Downregulated Bcl-2 can increase mitochondrial permeability and induce apoptosis (20) . In vitro studies have shown that TNF and IL-1 can induce Bcl-2 expression in RA-FLS, which protects RA-FLS in the inflammatory m�croenv�ronment (21) . In t��s st�dy, downreg�lated MEG3 led to an �ncreased express�on of Bcl-2 and decreased expression of Bax that promotes cell apoptosis of RA-FLS.
In addition to the excessive proliferation of FLS, degradation of art�c�lar cart�lage �s also one of t�e most ser�o�s pat�olog�cal features of RA, which may be explained by the overactivation of proteolyt�c enzyme system. Among t�em, MMPs are w�dely expressed in RA-FLS. MMPs are a group of zinc-dependent endopept�dases t�at degrade var�o�s components of t�e extracell�lar matr�x and are major proteases �nvolved �n cell m�grat�on and invasion (22, 23) . Multiple members of the MMPs family have already been reported to be associated with RA, such as collagenase MMP1 and matr�x lys�n MMP3. T�e gelat�nase subfamily includes two members, MMP2 and MMP9, which can d�gest collagenase-�nd�ced denat�red collagen. MMP2 and MMP9 can also d�gest ot�er matr�x components, �ncl�d�ng fibrillar collagen I and Ⅱ, and proteoglycans, thus participating in collagen degradation (24, 25) . Studies have confirmed that MMP2 and MMP9 are remarkably upregulated in RA and are closely related to t�e eros�on of art�c�lar cart�lage (26) . T��s experiment elucidated that downregulated MEG3 remarkably increases the expression levels of MMP2 and MMP9, but has no significant effect on MMP1 and MMP3.
In concl�s�on, downreg�lated MEG3 promotes prol�fera-tion and invasion, and inhibits apoptosis of FLS via STAT3 pat�way.
